Speakers

Expand/Collapse

Paolo Paissoni
R&D and Business Development Director
Procos S.p.A.

With more than 30 years of experience focused in research and development in the pharmaceutical industry, Dr. Paolo Paissoni, is passionate about innovation and cooperation in early stage drug development, as it sets the pathway for successful clinicals and commercialization.  Paolo received a Ph.D. in Chemistry from Turin University in 1984, where he graduated cum laude. For the duration of his career, Paolo has demonstrated strengths in assuring continuous technical innovations and contributed to the success of new products (NCEs) and optimized processes, having more than 15 published patents and a dedicated focus in anticancer small molecule development as well as a strong expertise in chromatography. Paolo has held positions at esteemed companies including Farmitalia Antibioticos S.p.A., for 16 years as the Head of R&D for Extraction and Chemistry, focused in the development of Anthracyclines class of products, and Procos S.p.A., for the last 13 years as the Head of R&D and Business Development.  Moreover, Paolo is currently serving as an active Board Member of CBC-Procos S.p.A since 2009.

Mike Sandoval
CEO
XEO Pharma

Day Two

Thursday 13th December 2018

2:00 pm | Case Study: The Rise of Virtual Biotechs – Complete Outsourced R&D Programs

Anita George
Executive Director, Global Sourcing R&D
Allergan

Day Two

Thursday 13th December 2018

11:45 am | Quick Fire: The Rising Stars of R&D Procurement – Who Speak the Language?

Akbar Alinani
Director, Sourcing Excellence R&D & BPO Lead
Bristol-Myers Squibb

Day Two

Thursday 13th December 2018

11:45 am | Quick Fire: The Rising Stars of R&D Procurement – Who Speak the Language?

Krista Emmons
Associate Director, Portfolio Relationship Management
Astellas

Krista Emmons is a Senior Portfolio Relationship Manager for Astellas Pharma Global Development in Northbrook, IL where she is responsible for strategic business relationships for a portfolio of service providers.  She has more than 15 years of experience supporting clinical research activities with key areas of focus in governance implementation, strategic sourcing initiatives, and clinical technology solutions such as IRT and eCOA.  Prior to joining Astellas in 2017, she was a Director of Portfolio Leadership at PAREXEL Informatics.  

Day Two

Thursday 13th December 2018

11:15 am | It Takes Time to Change – So Let’s Start Now: How Procurement Can Provide Governance & True Value Adding Services

Chris Gross
Director, Global Laboratory Supplies & Equipment Procurement
Merck & Co., Inc.

Day One

Thursday 13th December 2018

3:15 pm | Reflections & Actions

Sam Mercer
Business Development & Outsourcing
Eupraxia Pharmaceitoc

Deep Dive A

May 21, 2019

2:00 pm | How to Kick Start An Impactful R&D Procurement Team?

Shiva Kazerounian
Principal Scientist, In Vivo Pharmacology Lead
BERG Health

James Tornos
Senior Director, R&D Procurement
Pfizer

Dr James Tornos received a Bachelor of Science in Chemistry from University of Newcastle Upon Tyne, UK and then went on to study for a PhD at the University of Nottingham, UK in Organic Chemistry. James began his industrial career in 1998 with AstraZeneca as a Process Development Chemist in Loughborough, UK with responsibility for developing new manufacturing routes of synthesis of new drugs targeted towards respiratory diseases. In 2003, James then made a move into a strategic sourcing and procurement role having responsibility for the procurement and outsourcing of research services and Active Pharmaceutical Ingredients (API’s) within AstraZeneca. This role soon expanded and James became Global Lead for outsourcing across this category, working with global stakeholders to establish a strategic outsourcing model. In 2006, James joined Pfizer Global Research and Development based at the Sandwich, UK site as an Associate Director of Procurement and Outsourcing working across Research and Development leading strategic outsourcing. In 2010, James then moved to Pfizer’s global R&D headquarters in Connecticut to take up a role as Team Leader/Director of Procurement and Outsourcing supporting Pfizer Global Research. This role expanded in 2014 to cover Procurement and Sourcing of all pre-clinical Services and R&D Materials for Pfizer.

Day One

Thursday 13th December 2018

10:15 am | What Is Your Strategy?

Olivier Steinmetz
Head of Quality – Global Vaccines Strategic Alliances & Third Parties in R&D
GSK

Olivier Steinmetz is a Doctor of Pharmacy from Strasbourg University in France, he holds also a master of business management from Strasbourg Management School. With 20 years of experience, he held various Quality Assurance positions of increasing importance at Eli Lilly and Company’s parenteral products manufacturing site in Fegersheim, France and at GSK Vaccines global headquarters in Wavre, Belgium. Currently in charge of Strategic Alliances & Third Party Quality in R&D, his team partners with Vaccines R&D platforms to oversee 500+ GxP and non-GxP vendors.

Day Two

Thursday 13th December 2018

10:15 am | Success Story: Quality as a Key Partner in R&D Supplier Performance Management and Vendor Oversight

Richard Milne
Vice President & General Manager, Digital Science
Thermo Fisher Scientific

As Vice President and General Manager for Digital Science, Richard is responsible for driving revenue and customer engagement with our core digital science and informatics capabilities. Richard Milne has more than 20 years of experience in the world of digital marketing, eBusiness, customer experience and developing web properties. Richard is passionate about the changing nature of business and has long believed the future will be digital---where automation, AI, data science, IoT, connected devices and eCommerce become the main ways customers interact with companies. Prior to joining the company 13 years ago, he worked as an internet technologies consultant for the Scottish Government. And before that, he championed early digital marketing by building eCommerce websites and leading direct marketing campaigns for large CPG clients. Richard is inspired by the changing landscape of commerce, the power of partnership and the ever-increasing value of platform thinking.

Day One

Thursday 13th December 2018

4:30 pm | IoT and the Future of Digital Science

Umar Salahuddin
Director of R&D Sourcing, Global Procurement
Biogen

Day Two

Thursday 13th December 2018

9:45 am | Opening Address: Clinical Operations vs Clinical Procurement – Eliminating the Barriers

Karan Paruvangada
Strategic Sourcing Leader
Bill & Melinda Gates Medical Research Institute

Day One

Thursday 13th December 2018

12:00 pm | Debate: Who Do You Need to Get On Board?

Peter McGree
Director of R&D Procurement
Gilead

Day One

Thursday 13th December 2018

12:00 pm | Debate: Who Do You Need to Get On Board?

Mark Peymer
Head & Associate Director, Global R&D Alliance Management
Johnson & Johnson

Day One

Thursday 13th December 2018

2:15 pm | Optimization & Alignment of R&D Strategy and Procurement to Drive Productivity

Pat Magnafichi
Director of Procurement
EXELIXIS

Day One

Thursday 13th December 2018

12:00 pm | Debate: Who Do You Need to Get On Board?

Robert Fitzmaurice
Senior Sourcing Manager
Regeneron

Day One

Thursday 13th December 2018

5:00 pm | Case Study: Smart Guided Buying Adoption in Early R&D

James Murphy
Procurement Manager
bluebird bio

Day One

Thursday 13th December 2018

2:45 pm | Painting the Big Picture – Total Spend vs. Supplier Management

Andrew Wolfe
President & CEO
Wolfe Procurement

Currently the President & CEO of Wolfe Procurement. Andrew is a seasoned procurement executive with over 24 years’ experience.   He has a proven track record of executing complex, high-value strategic sourcing initiatives and supplier management programs globally.  He is an expert negotiator focusing on savings and improved supplier offerings.  Andrew has experience leading high performing teams, procurement transformations, acquisition integrations and outsourcing initiatives. Prior to Wolfe Procurement, Andrew has held senior leadership positions at OpenText and Manulife Financial.   Andrew is also a CSCMP.  

Mark Davis
Principal
NegotiumBio, LLC

Deep Dive A

May 21, 2019

2:00 pm | How to Kick Start An Impactful R&D Procurement Team?

Philip Ideson
Managing Director
Art of Procurement

Deep Dive A

May 21, 2019

2:00 pm | How to Kick Start An Impactful R&D Procurement Team?

Adam Shayevitz
President
Strategic Sourcing Dynamics, LLC

Adam Shayevitz has over 30 years’ experience in Global Strategic Sourcing and building supplier partnerships. His consulting firm works with technology companies from start-ups to Fortune 500's, setting up manufacturing sources of electromechanical parts and assemblies from prototyping through volume manufacturing. His Strategic Sourcing methodology allows clients to avoid months of new supplier validation trial and error. Adam focuses on optimizing supplier selection, accelerating new product introduction, and improving cost and quality through early design cycle supplier DFMA partnering.  He is an expert inter-cultural negotiator with extensive experience achieving win-win solutions. Adam received an MBA in International Business from Babson's Graduate School of Business and a BA in Economics from Skidmore College.  Prior to founding Strategic Sourcing Dynamics LLC, Adam has held Senior Strategic Sourcing positions at Mascon, Parker Hannafin Corp., and Rethink Robotics.